Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inference for the cost-effectiveness acceptability curve and cost-effectiveness ratio.

A O'Hagan1, J W Stevens, J Montmartin

  • 1Statistical Services Unit, University of Sheffield, South Yorkshire, England. a.ohagan@sheffield.ac.uk

Pharmacoeconomics
|August 18, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preventing the Progression to Type 2 Diabetes Mellitus in Adults at High Risk: A Systematic Review And Network Meta-Analysis of Lifestyle, Pharmacological and Surgical Interventions.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

The Cost-Effectiveness of Biologic Dmards in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional Dmards.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal-An Evidence Review Group Perspective.

PharmacoEconomics·2016
Same author

Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins.

The British journal of surgery·2014
Same author

Authors' reply: systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication (Br J Surg 2012; 99: 1630-1638).

The British journal of surgery·2013
Same author

Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation.

Health technology assessment (Winchester, England)·2013
Same journal

Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia.

PharmacoEconomics·2026
Same journal

Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update.

PharmacoEconomics·2026
Same journal

Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment.

PharmacoEconomics·2026
Same journal

A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations.

PharmacoEconomics·2026
Same journal

Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration.

PharmacoEconomics·2026
Same journal

Correction: Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder Group.

PharmacoEconomics·2026
See all related articles

This study introduces simpler Bayesian and frequentist methods for cost-effectiveness (C/E) acceptability curves from clinical trials. The new approach accounts for variance uncertainty, offering more reliable inferences than standard methods.

Area of Science:

  • Health economics
  • Biostatistics
  • Clinical trial analysis

Background:

  • Cost-effectiveness (C/E) analysis is crucial for healthcare decision-making.
  • Existing Bayesian methods for C/E acceptability curves often oversimplify variance estimation.
  • Frequentist inference for C/E ratios can yield unreliable results.

Purpose of the Study:

  • To present simplified Bayesian and frequentist inference methods for C/E acceptability curves.
  • To address limitations in current Bayesian approaches, particularly regarding variance uncertainty.
  • To offer a more robust alternative to standard frequentist C/E ratio inference.

Main Methods:

  • Development of a simple Bayesian computation for the C/E acceptability curve.
  • Introduction of a frequentist analogue to the Bayesian method.

Related Experiment Videos

  • Utilizing distributional assumptions that account for uncertainty in estimated variances.

    • Main Results:

    • The proposed Bayesian computation is simpler and more accurate than existing methods.
    • The frequentist analogue provides a reliable alternative for C/E ratio inference.
    • The methods correctly incorporate uncertainty in variance estimation, unlike normal posterior assumptions.

    Conclusions:

    • The presented methods offer improved accuracy and simplicity for Bayesian and frequentist C/E acceptability curve analysis.
    • Accounting for variance uncertainty is critical for reliable cost-effectiveness inference.
    • A Bayesian interval is recommended over standard frequentist procedures for C/E ratio inference.